Sana Biotechnology, Inc.SANANASDAQ
Loading
Operating Income Growth AcceleratingAccelerating
Percentile Rank92
3Y CAGR+165.7%
Year-over-Year Change
Year-over-year operating income growth rate
3Y CAGR
+165.7%/yr
Quarterly compound
Percentile
P92
Near historical high
vs 3Y Ago
18.8x
Strong expansion
Streak
2 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 95.78% |
| Q3 2025 | 54.18% |
| Q2 2025 | -87.59% |
| Q1 2025 | 0.46% |
| Q4 2024 | 17.64% |
| Q3 2024 | -25.09% |
| Q2 2024 | 55.41% |
| Q1 2024 | -22.19% |
| Q4 2023 | -4054.93% |
| Q3 2023 | 98.12% |
| Q2 2023 | -38.35% |
| Q1 2023 | -2.77% |
| Q4 2022 | 5.10% |
| Q3 2022 | -18.22% |
| Q2 2022 | -130.09% |
| Q1 2022 | 71.53% |
| Q4 2021 | -33.38% |
| Q3 2021 | -549.71% |
| Q2 2021 | 110.26% |
| Q1 2021 | -59.50% |
| Q4 2020 | -119.43% |
| Q3 2020 | 41.25% |
| Q2 2020 | -164.18% |
| Q1 2020 | 26.21% |
| Q4 2019 | 0.00% |